Miromatrix Medical Inc.
MIRONASDAQHealthcare
$3.39
+$0.02(+0.59%)
Market Cap$92951088
P/E Ratio—
52W High$4.35
52W Low$0.906
Miromatrix Medical Inc. (MIRO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MIRO · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 14, 2023EPS Actual
-$0.24
Est. -$0.18 · -33.3%
Revenue
$0.00B
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 14, 2023
After Market Close
▼ Miss EPS
MIRO reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2024 | Aug 12, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | May 9, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Mar 29, 2024 | -$0.18 | — | — | — | — | — |
| ▼ Q4 FY2023 | Nov 14, 2023 | -$0.18 | -$0.24 | -33.3% | $0.00B | — | — |
| ▲ Q3 FY2023 | Aug 14, 2023 | -$0.32 | -$0.24 | +25.0% | $0.00B | — | — |
| ▲ Q2 FY2023 | May 11, 2023 | -$0.34 | -$0.33 | +2.9% | $0.00B | — | — |
| ▲ Q1 FY2023 | Mar 31, 2023 | -$0.37 | -$0.33 | +10.8% | $0.00B | — | — |
| ▼ Q4 FY2022 | Nov 14, 2022 | -$0.33 | -$0.37 | -12.1% | $0.00B | — | — |
Q3 FY2024
Aug 12, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 9, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 29, 2024
EPS Actual
—
EPS Est.
-$0.18
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 14, 2023Miss
EPS Actual
-$0.24
EPS Est.
-$0.18
EPS Surpr.
-33.3%
Revenue
$0.00B
Q3 FY2023
Aug 14, 2023Beat
EPS Actual
-$0.24
EPS Est.
-$0.32
EPS Surpr.
+25.0%
Revenue
$0.00B
Q2 FY2023
May 11, 2023Beat
EPS Actual
-$0.33
EPS Est.
-$0.34
EPS Surpr.
+2.9%
Revenue
$0.00B
Q1 FY2023
Mar 31, 2023Beat
EPS Actual
-$0.33
EPS Est.
-$0.37
EPS Surpr.
+10.8%
Revenue
$0.00B
Q4 FY2022
Nov 14, 2022Miss
EPS Actual
-$0.37
EPS Est.
-$0.33
EPS Surpr.
-12.1%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.76 | $1.54 | $1.32 | 0 |
| Q2 FY2024 | $1.53 | $1.34 | $1.15 | 0 |
| Q1 FY2024 | $1.80 | $1.58 | $1.35 | 1 |
| Q4 FY2023 | $-0.24 | $-0.21 | $-0.18 | 1 |
| Q3 FY2023 | $-0.24 | $-0.21 | $-0.18 | 2 |
| Q2 FY2023 | $-0.37 | $-0.32 | $-0.27 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2023 | Nov 14, 2023 | -33.3% | $3.34 | $3.34 | +0.00% |
| ▲ Q3 FY2023 | Aug 14, 2023 | +25.0% | $1.28 | $1.21 | -5.47% |
| ▲ Q2 FY2023 | May 11, 2023 | +2.9% | $1.12 | $1.12 | +0.00% |
| ▲ Q1 FY2023 | Mar 31, 2023 | +10.8% | $1.49 | $1.68 | +12.75% |
| ▼ Q4 FY2022 | Nov 14, 2022 | -12.1% | $4.35 | $4.17 | -4.14% |
| ▼ Q3 FY2022 | Aug 15, 2022 | -21.2% | $2.78 | $2.76 | -0.58% |
| ▼ Q2 FY2022 | May 16, 2022 | -20.7% | $3.94 | $3.87 | -1.78% |
| ▼ Q1 FY2022 | Mar 30, 2022 | -80.0% | $3.72 | $3.78 | +1.61% |
Q4 FY2023+0.00%
Report Date
Nov 14, 2023
EPS Beat/Miss
-33.3%
Price Before
$3.34
Price After
$3.34
Q3 FY2023-5.47%
Report Date
Aug 14, 2023
EPS Beat/Miss
+25.0%
Price Before
$1.28
Price After
$1.21
Q2 FY2023+0.00%
Report Date
May 11, 2023
EPS Beat/Miss
+2.9%
Price Before
$1.12
Price After
$1.12
Q1 FY2023+12.75%
Report Date
Mar 31, 2023
EPS Beat/Miss
+10.8%
Price Before
$1.49
Price After
$1.68
Q4 FY2022-4.14%
Report Date
Nov 14, 2022
EPS Beat/Miss
-12.1%
Price Before
$4.35
Price After
$4.17
Q3 FY2022-0.58%
Report Date
Aug 15, 2022
EPS Beat/Miss
-21.2%
Price Before
$2.78
Price After
$2.76
Q2 FY2022-1.78%
Report Date
May 16, 2022
EPS Beat/Miss
-20.7%
Price Before
$3.94
Price After
$3.87
Q1 FY2022+1.61%
Report Date
Mar 30, 2022
EPS Beat/Miss
-80.0%
Price Before
$3.72
Price After
$3.78
Avg Beat Reaction+2.43%
Avg Miss Reaction-0.98%
Beat Rate3 / 8 quarters
Largest Move+12.75% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MIRO ends December
Miromatrix Medical Inc. (MIRO) most recently reported earnings on November 14, 2023 for Q4 FY2023, posting EPS of $-0.24 — missing the analyst consensus of $-0.18 by -33.3%. The next MIRO earnings date is expected around September 1, 2026.
Each quarter, investors track MIRO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MIRO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MIRO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MIRO earnings · 5 questionsMiromatrix Medical Inc.'s next earnings report is expected around September 1, 2026. MIRO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MIRO historically reports after market close (AMC).
MIRO earnings datewhen is MIRO earningsMIRO next earnings datewhen does MIRO report earningsMIRO earnings calendar
▸ Source: FMP · Miromatrix Medical Inc. SEC filings · US GAAP · Miromatrix Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026